Pralatrexate (PDX) produces durable complete remissions in patients with chemotherapy resistant precursor and peripheral T-Cell lymphomas: Results of the MSKCC phase I/II experience Meeting Abstract
| Authors: | O'Connor, O. A.; Hamlin, P. A.; Gerecitano, J.; Portlock, C. S.; Noy, A.; Moskowitz, C.; Straus, D. J.; Sarasohn, D.; Dumitrescu, O.; Pappanicholaou, J.; Neylon, E.; Zelenetz, A. D.; Saunders, M. E.; Mould, D. R.; Fleischer, M.; Sirotnak, F.; Horwitz, S. M. |
| Abstract Title: | Pralatrexate (PDX) produces durable complete remissions in patients with chemotherapy resistant precursor and peripheral T-Cell lymphomas: Results of the MSKCC phase I/II experience |
| Meeting Title: | 48th Annual Meeting of the American Society of Hematology (ASH) |
| Journal Title: | Blood |
| Volume: | 108 |
| Issue: | 11 Pt. 1 |
| Meeting Dates: | 2006 Dec 9-12 |
| Meeting Location: | Orlando, FL |
| ISSN: | 0006-4971 |
| Publisher: | American Society of Hematology |
| Date Published: | 2006-11-01 |
| Start Page: | 122A |
| End Page: | 123A |
| Language: | English |
| ACCESSION: | WOS:000242440000401 |
| PROVIDER: | wos |
| PUBMED: | 17139767 |
| DOI: | 10.1182/blood.V108.11.400.400 |
| Notes: | --- - Meeting Abstract: 400 - 48th Annual Meeting of the American-Society-of-Hematology - DEC 09-12, 2006 - Orlando, FL - Part 1 - "Source: Wos" |
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
